Tomonori Kaneko

Title: Tomonori Kaneko: Innovator in SH2 Domain Variants

Introduction

Tomonori Kaneko is a notable inventor based in London, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of SH2 domain variants. His work focuses on enhancing the binding affinity of these domains for phosphotyrosine-containing peptides, which has important implications for medical research and treatment.

Latest Patents

Kaneko holds a patent for SH2 domain variants. The present invention relates to variant SH2 domains designed for binding a phosphotyrosine (pTyr)-containing peptide. These variants include a parent SH2 domain with at least one amino acid substitution in a specific region of 15 amino acid positions. This substitution increases the affinity of the variant SH2 domain for the pTyr-containing peptide compared to the parent SH2 domain. The application also discusses methods for using these variants in treating protein kinase-associated disorders, diagnosing or prognosing such disorders, isolating and measuring pTyr-containing molecules, and utilizing them as reagents in research.

Career Highlights

Throughout his career, Tomonori Kaneko has worked with prestigious institutions, including the University of Toronto and The University of Western Ontario. His research has contributed to advancements in understanding protein interactions and their implications in various diseases.

Collaborations

Kaneko has collaborated with notable researchers such as Sachdev Singh Sidhu and Shun-Cheng Li. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Tomonori Kaneko's innovative work on SH2 domain variants showcases his commitment to advancing biochemistry and medical research. His contributions are paving the way for new treatments and diagnostic methods in the field.